Home     Log in

Archive for February, 2009

Cancer - To See A Doctor Is To Be Told When You Are Going To Die

February 27th, 2009 by admin | No Comments | Filed in Uncategorized

Eddy from Indonesia came to our centre on 18 June 2007. He brought his father-in-law who suffer from to see us. This was Eddy’s second visit here. His first visit was on 22 April 2005 when he came with a colleague to seek our help regarding his colleague’s father, Sugi, who had . During this June 2007 visit, I enquired from Eddy about Sugi’s health – is he still alive? The answer was: “Sure, he is doing well.” I was indeed surprised and was really happy with this wonderful news. I searched out Sugi’s file to write this almost forgotten story.

Sugi (not real name) is a non-smoker. He was 67 years old in August 2003, when he suffered from sores in his mouth and had jaundice. He went to see a doctor who did a CT scan and found cancer in his lungs. The doctor told Sugi that he only had six months to live, in spite of the fact that Sugi appeared healthy. Someone told Sugi about CA Care and he decided to take our herbs: Capsule A, Lung 1 and Lung 2 teas. Sugi took the herbs for eight months but his jaundice still persisted. He lost faith in our therapy and decided to take herbs from other sources. But Sugi did not receive any medical treatment.

On 22 April 2005, Sugi’s son came to Penang and seek our help. He told us that Sugi went to see a doctor again two weeks before this visit and the doctor again told Sugi that he only had four months to live. Sugi’s son said: “In the first visit to the doctor, my father was told that he only had six months to live and now it has been two years and he is still alive. Last two weeks, the doctor told my father he only had four months to live. The doctor suggested that my father do an operation to remove the tumours but my father refused.”

After updating Sugi’s condition, we suggested that Sugi take Capsule A, Lung 1 and Lung 2, C-tea, T & E, and S & M teas.

On 1 July 2005, we received an e-mail from Sugi’s son with the following message:

“After visiting you last April 2005, I would like to share with you about my dad’s . My dad has been recovering significantly in terms of increased weight (from 54 kg to 61 kg). Visually he looked better and he felt better too. I sincerely thank you and appreciate all your kind advices and herbs.”

I e-mailed Sugi’s son requesting for an update of his father’s health. On 2 July 2007, I received his reply (original text in Bahasa Indonesia).

Hello, Dr. Chris,

It has been a long time since I last wrote you about my father’s condition. We are indeed grateful to the Almighty God for through Dr. Chris’s hands, that my father is able to remain alive up to this day. Currently, my father is able to do what he wanted to do as a normal person.

Let me answer your questions:
a) How is your father’s health currently? Can eat? Can sleep? Can move without any problems?

My father’s health, based on visual appearance is very good. His appetite is very good and he is still observing the diet restriction as written by Dr. Chris in his book: Food & Cancer. Every morning, my father walks for three km to keep fit. He sleeps very well. He is mobile without any problem.

b) After you and Eddy came to see me in Penang until now, has your father ever gone to see any doctor?

My father went to see his doctor only once. He received an injection to increase his immunity. After that, my father has been receiving this injection every month. This therapy seems to be good but I don’t know about its effect on his cancer.

c) Was your father on any other herbs besides our CA Care herbs?

He was on your herbs only. But since the past three months, my father stopped taking your herbs. I guessed he was bored with the herbs.

Comments

This is one case which almost slipped out of our records. Sugi come from Central Java and when he started taking herbs he did not come to see us personally. So there was not much communication between us. It was unfortunate that in the first instance his jaundice did not go away after taking the herbs. The reason is obvious – he was not given any Jaundice Tea to take. Our experience shows that Jaundice Heat or Jaundice Cold tea, is effective for such condition. Though Sugi suffered from jaundice, it was surprising that the doctor indicated that his liver was in good health.

This story highlighted one sad aspect about scientific medicine. When patients are diagnosed with (or for that matter any cancer), some doctors invariable try to play God and give their prognosis. “You have three months to live” or “You have six months to live.” Such comment is indeed very destructive. I wonder what purpose such negative comment serves. Is this a way of putting “fear and terror” into patients? When patients are reduced to a state of “helplessness and hopelessness” they become more compliant with whatever treatments suggested. To the doctors, surgery, and radiotherapy are the only ways to deal with cancer – other ways are “hocus pocus” and unproven.

Unfortunately this story proves otherwise. Without these evasive treatments, Sugi was and is better off. He maintained his good health and well-being – physically, emotionally and financially. It has been almost four years since Sugi was diagnosed with . Let us pray that Sugi will continue to live many more years to come. Sugi’s success defies medical logic, if you believe that there is such a thing as logic!

For more information about complementary cancer therapy visit: cacare.com cacare.com, NaturalHealingForYou.com NaturalHealingForYou.com, BookOnCancer.com BookOnCancer.com

Tags: , , ,

Related posts

Tags: , , ,

An Introduction To Minimally Invasive BPH Treatment

February 27th, 2009 by admin | No Comments | Filed in Uncategorized

For many men suffering from BPH (a swollen or enlarged prostate) drug treatment is the answer and can reduce BPH symptoms to an acceptable level. For others however medication does not prove effective or is not a viable option and the doctor may recommend one of a number of minimally invasive surgical procedures.

The first procedure to consider is catheterization. Catheterization involves the insertion of a catheter into the penis and bladder to act as a drain and is normally considered only as a temporary solution. It is used mainly for patients who are waiting for the effects of drug treatment to kick in (some drugs used in BPH treatment can take 6 to 12 months before they start to show results) or for other surgical treatments. It can also be used to assist in treating infections.

The next procedure to consider is Holmium laser enucleation prostate (HoLEP). This procedure, which is carried out under anesthesia and requires a short 1 or 2 day stay in hospital, involves the insertion of a resectoscope through the penis and into the urethra. A laser is then passed through the resectoscope and is used to vaporize prostate tissue.

A similar procedure to HoLEP is that of interstitial laser coagulation. This procedure is again carried out under anesthetic, although patients are not normally required to remain in hospital overnight. In this case a cystoscope, which is a metal tube through which a visual lens and laser can be passed, is used and tissue is burnt away from the prostate using laser energy.

In cases where a patient cannot tolerate anesthesia a prostatic stent may be used. Stenting involves the placement of a spring-like device into the urethra at the point at which it passes through the prostate in order to hold the urethra open. Unfortunately there are a number of problems associated with this form of BPH treatment and it is normally only used for patients who suffer from additional medical problems and for whom surgery would present unacceptable risks.

Transurethral microwave thermotherapy of the prostate (TUMT) is a form of minimally invasive surgery that does not require hospitalization or anesthesia and is carried out using a local anesthetic and oral pain medication. In this procedure a catheter is inserted through the penis and computer controlled microwaves are used to heat, and thus shrink, sections of the prostate.

Another office-based procedure is the transurethral radio frequency needle ablation of the prostate (TUNA). Here light anesthesia and medication is used to make the patient sleepy and prostate tissue is heated using radio frequency energy transmitted through a series of needles placed directly into the prostate. This procedure initially causes a swelling of the prostate, followed by shrinkage, and patients will usually be required to use a catheter for a short period after the procedure.

There are clearly a number of different forms of minimally invasive surgery available for BPH treatment and patients will need to discuss each of these with their doctor to determine which will best suit their particular circumstances.

For more information about prostatecancerexplained.com/bph.html” target=”_blank BPH treatment please visit prostatecancerexplained.com” target=”_blank Prostate Cancer Explained.

Tags:

Related posts

Tags:

An Overview of Skin Cancer

February 27th, 2009 by admin | No Comments | Filed in Uncategorized

Cancer is a scary subject and comes in many forms. Skin cancer is one of the more prevalent versions and, unfortunately, one most people do not take seriously enough.

Imagine sitting in a doctor’s office and being told you have cancer. Although has come a long way, it would still be a devastating moment. Are you going to die? Is it curable? Why you? These are the types of questions that will undoubtedly come to mind immediately. With many forms of cancer, there is a certain luck of the draw element as to why you get them. Skin cancer, however, is one you can take steps to avoid.

What is ? It is a malignant growth on the skin, typically forming on the epidermis or outer layer of the skin. It is often associated with repeated sun burns or extensive exposure to the sun over time. It is also becoming more common due to increased ultraviolet radiation penetration in the atmosphere.

Skin cancer typically can be categorized in three ways. Malignant is the worst and is fatal if not diagnosed and treated early. It is, however, the least prevalent of the categories. Basal cell carcinoma is the most common, has a hereditary element and is rarely fatal. It tends to be isolated and is often treated with surgery or topical . Squamous cell carcinoma is a form of cancer that occurs on both the skin and internal organs. It can be caused by many things including exposure to the sun and can metastasize or spread through the body.

The nature of is such that it often can be avoided if precautionary steps are taken. If you enjoy laying on the beach or working outside, using proper sun block is simple and effective. The key is to use it liberally and frequently. While this seems like common sense, the sheer number of cases reported each year indicate that people are not using it. Laziness is most likely the cause. If you fall in this category, do your really want to risk , particularly malignant that can kill you?

If you are going to be out in the sun, whether skiing, sitting on a beach, hiking or working, make sure to protect yourself. Using sun screen is a minor task that can prevent big problems.

John Grimes is with All Terrain - makers of natural

Tags: , , ,

Related posts

Tags: , , ,

He Died After Chemotherapy And A Shot of Blood-Count-Boosting (Epoetin) Injection

February 26th, 2009 by admin | No Comments | Filed in Uncategorized

Some years ago, one young man came to see me for his cancer. He was prescribed some herbs which he did not take. He preferred to go for instead. Not too long after that his wife came to my house in the middle of the night and asked for help. She told me that after , her husband’s red blood counts dropped drastically. The doctor gave him an injection to boost up the blood counts. He suffered a blood clot in his thigh and had to undergo an emergency operation. She wanted me to help him with the herbs. But it was not to be, her husband died soon afterwards.

In the early days of my practice, I did not document patients who came to see me. So, I only have vague recollection of some outstanding cases. This was one outstanding case that I remember, involving a young professional. When he had cancer, I could see the agony and hopelessness in the face of his young wife.

This case would not have resurface and find itself in print if not for some articles I have just read in the net about erythropoiesis stimulating agents (ESAs). ESA is commonly used to treat anemia, i.e., a lower than normal number of red blood cells. Examples of such drugs are Procrit, Epogen and Aranesp. These are synthetic, genetically engineered version of a natural glycoprotein known as erythroprotein. The US-FDA had approved the use of ESAs to treat anemia in patients with chronic kidney failure and in patients with cancer after had lowered their blood counts. To patients in Malaysia, each injection cost a good tidy sum of money.

According to Alison Tonka, associate editor of the British Medical Journal (BMJ) “thousands of patients worldwide rely on synthetic ESAs to alleviate the anemia that accompanies chronic renal disease and for cancer.” Two news articles in the BMJ had these titles: “Safety of anemia drug erythopoitin is to be reviewed” and “FDA calls for warning on anaemia drugs amid reports of incentives to doctors.” The main message from these articles is that more patients treated with ESAs died from the treatment rather than live longer or are helped. That is to say, ESAs increase the risk of death. Studies also showed that at a dose higher than indicated ESAs could cause increased risk of blood clots, stroke and heart attack. In patients with head and neck cancer, higher doses of ESAs promoted tumour growth.

In November 2006, February and March 2007, the US-FDA put out safety alerts informing the public about this safety concerns. From the net, I learn the following:

1. ESAs can cause serious and life-threatening side effects.

2. A greater number of deaths occurred in patients treated with these blood-count-boosting injections than in patients who did not receive .

3. ESAs cause increased rate of tumour growth in patients who had radiation therapy for their head and neck cancers and for their metastatic .

4. ESAs cause higher chance of death and increased number of blood clots, strokes, heart failure and heart attacks in patients with chronic kidney failure.

All users of this blood-count-boosting drugs need to be told that they are at increased risk of death as well as serious cardiovascular complications including stroke, heart attack, blood clots to the heart, lungs, brain and major blood vessels. Those with chronic kidney failure given ESAs may suffer from seizures and hypertensive encephalopathy, i.e., swelling of the brain caused by very high blood pressure.

I now know why this young man met his premature death after plus a shot of erythropoiesis stimulating agent (ESA) that the doctor gave him. Goethe, a German philosopher once wrote: “There is nothing more frightening than active ignorance.”

For more information about complementary cancer therapy visit: cacare.com cacare.com, NaturalHealingForYou.com NaturalHealingForYou.com, BookOnCancer.com BookOnCancer.com

Tags: , ,

Related posts

Tags: , ,

Prostate Cancer Treatment and Heart Disease

February 26th, 2009 by admin | No Comments | Filed in Uncategorized

Many men with are treated with hormones that block the effects of testosterone, the primary male sex hormone. This is because many prostate cancers thrive on testosterone.

By depriving them of testosterone, the cells “starve” and die. This treatment is called androgen suppression therapy. Usually, it is men with aggressive and those with prostate cancers that cause the prostate gland to enlarge who benefit the most from androgen suppression therapy.

Nearly every treatment that has benefits also has risks. Physicians must always weigh the benefits and risks of a treatment. Of course, the potential of androgen suppression therapy to prolong the life of men with and even increase the likelihood of it being cured cannot be disregarded. Nonetheless, the side effects of androgen suppression therapy include the loss of sex drive, anemia, osteoporosis, weight gain, decreased muscle mass, increase in bad cholesterol (LDL) and decrease in good cholesterol (HDL).

The alteration of LDL and HDL by androgen suppression therapy can potentially increase the risk of coronary artery disease and heart attacks. Therefore, this possibility was analyzed from data pooled from three randomized studies performed in the United States, Australia, and New Zealand, respectively.

One thousand three hundred seventy two (1, 372) men who received androgen suppression therapy in addition to radiation therapy to the prostate gland were followed for at least five years. The researchers found that men over 65 who received androgen suppression therapy for six months had an earlier onset of heart attacks, perhaps by two and a half years.

Does this mean men should not be treated with androgen suppression therapy, especially in the group in whom the benefits of hormonal therapy outweigh the risks? It does not; instead, the implication is that men who will benefit from hormonal therapy to avoid dying from but who also have risk factors for coronary artery disease should be referred to a cardiologist.

Men can then be assessed for and even treated for heart disease before they begin hormonal therapy. They can then undergo androgen suppression therapy without adverse effects on their hearts.

Also, more good news is that new studies are being developed to determine the optimal duration of androgen suppression therapy. By making hormonal therapy intermittent, such as six months on androgen suppression therapy and six months off, men might achieve the same survival endpoint with less toxicity than continuous androgen suppression therapy.

Dr. Kornmehl is a board certified radiation oncologist at Passaic Beth Israel Regional Medical Center, Passaic, NJ and author of the critically acclaimed consumer health book, “The Best News About Radiation Therapy” (M. Evans, 2004). Her website is RTSupportDoc.com RTSupportDoc.com

Tags: ,

Related posts

Tags: ,